These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32642965)

  • 1. Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors.
    Epstein RS; Aapro MS; Basu Roy UK; Salimi T; Krenitsky J; Leone-Perkins ML; Girman C; Schlusser C; Crawford J
    Adv Ther; 2020 Aug; 37(8):3606-3618. PubMed ID: 32642965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers.
    Epstein RS; Weerasinghe RK; Parrish AS; Krenitsky J; Sanborn RE; Salimi T
    J Med Econ; 2022; 25(1):108-118. PubMed ID: 34927520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.
    Epstein RS; Basu Roy UK; Aapro M; Salimi T; Moran D; Krenitsky J; Leone-Perkins ML; Girman C; Schlusser C; Crawford J
    Patient Prefer Adherence; 2021; 15():453-465. PubMed ID: 33658769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of myelosuppression on quality of life of patients treated with chemotherapy.
    Crawford J; Herndon D; Gmitter K; Weiss J
    Future Oncol; 2024; 20(21):1515-1530. PubMed ID: 38587388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology.
    Balducci L; Falandry C; List A
    Curr Oncol Rep; 2022 Dec; 24(12):1695-1703. PubMed ID: 35986858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
    Traeger L; McDonnell TM; McCarty CE; Greer JA; El-Jawahri A; Temel JS
    Cancer; 2015 Nov; 121(21):3905-13. PubMed ID: 26194461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories and predictors of state and trait anxiety in patients receiving chemotherapy for breast and colorectal cancer: Results from a longitudinal study.
    Schneider A; Kotronoulas G; Papadopoulou C; McCann L; Miller M; McBride J; Polly Z; Bettles S; Whitehouse A; Kearney N; Maguire R
    Eur J Oncol Nurs; 2016 Oct; 24():1-7. PubMed ID: 27697271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    Pearce A; Haas M; Viney R; Pearson SA; Haywood P; Brown C; Ward R
    PLoS One; 2017; 12(10):e0184360. PubMed ID: 29016607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in recommendations for myelosuppressive chemotherapy for the treatment of solid tumors.
    Smith RE
    J Natl Compr Canc Netw; 2006 Aug; 4(7):649-58. PubMed ID: 16884668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.
    Ferrarotto R; Anderson I; Medgyasszay B; García-Campelo MR; Edenfield W; Feinstein TM; Johnson JM; Kalmadi S; Lammers PE; Sanchez-Hernandez A; Pritchett Y; Morris SR; Malik RK; Csőszi T
    Cancer Med; 2021 Sep; 10(17):5748-5756. PubMed ID: 34405547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer: A retrospective study from community oncology practices.
    Hart L; Ogbonnaya A; Boykin K; Deyoung K; Bailey R; Heritage T; Lopez-Gonzalez L; Huang H; Gordan L
    Cancer Med; 2023 Apr; 12(8):10020-10030. PubMed ID: 37000119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care.
    Ben-Arye E; Dahly H; Keshet Y; Dagash J; Samuels N
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1825-1833. PubMed ID: 29980837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
    Passildas J; Collard O; Savoye AM; Dohou J; Ginzac A; Thivat E; Durando X; Kwiatkowski F; Penault-Llorca F; Abrial C; Mouret-Reynier MA
    Clin Breast Cancer; 2019 Feb; 19(1):e74-e84. PubMed ID: 30448088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany.
    Link H; Nietsch J; Kerkmann M; Ortner P;
    Support Care Cancer; 2016 Jan; 24(1):367-376. PubMed ID: 26081593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a patient-tailored complementary/integrative medicine programme on disturbed sleep quality among patients undergoing chemotherapy.
    Kerner H; Samuels N; Ben Moshe S; Sharabi IS; Ben-Arye E
    BMJ Support Palliat Care; 2020 Sep; 10(3):e21. PubMed ID: 28710110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.
    Weiss J; Goldschmidt J; Andric Z; Dragnev KH; Gwaltney C; Skaltsa K; Pritchett Y; Antal JM; Morris SR; Daniel D
    Clin Lung Cancer; 2021 Sep; 22(5):449-460. PubMed ID: 33895103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.